Washington, D.C. (May 31, 2019) — The ALS Association is pleased to announce the continuation of its national collaboration with Mitsubishi Tanabe Pharma America, Inc. (MTPA), which has resulted in significant support of the Walk to Defeat ALS program, various national conferences and events, and an extensive care grant distributed to The ALS Association chapter network.

“We are grateful for Mitsubishi Tanabe Pharma America’s continued willingness to rise to the challenge and support us in our fight for a world without ALS,” said Tina Zeff, executive vice president of development for The ALS Association.

The collaboration with MTPA helps the Association address obstacles people living with ALS often face when trying to access care-related services.

"We are pleased to support The ALS Association and its important work in communities across the United States,” said Atsushi Fujimoto, President, Mitsubishi Tanabe Pharma America. “We share a common goal to help as many people with ALS and their families as possible access the care and service they need to extend both length of life and quality of life.”

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within five years of diagnosis. For unknown reasons, veterans are twice as likely to develop ALS as the general population. There is no cure.

About Mitsubishi Tanabe Pharma America, Inc. 
Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation’s (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America. It was established by MTPC to commercialize approved pharmaceutical products in North America with plans to expand its product line through collaborations with partners. For more information, please visit www.mt-pharma-america.com or follow us on Twitter and Facebook.

About The ALS Association 
The ALS Association is the largest private funder of ALS research in the world. The Association funds global research collaborations, provides assistance for people with ALS and their families through our nationwide network of chapters and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association builds hope and enhances quality of life while urgently searching for new treatments and a cure. For more information about The ALS Association, visit our website at www.als.org.